Project Grant 2234619
Award Date
8/1/23
Completion Date
7/31/26
Dollars Obligated
$550K
Federal Agency
National Science Foundation
Federal Grant Program
47.084
Assistance Type
Project Grant
Place of Performance
Stillwater, OK 74078, USA
Similar Awards
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $604,750 to Scientific Horizons Consulting LLC to develop and evaluate a novel inhalation device prototype for the pulmonary delivery of anti-inflammatory agents to treat inflammation and pain associated with chronic obstructive pulmonary disease (COPD). The key objectives are to: 1) investigate the feasibility of delivering...
Intelligent Medicine Inc. received a $275,842 National Science Foundation Project Grant to develop a cloud-based simulation platform for modeling airborne infectious disease spread. Funded through NSF's Technology, Innovation, and Partnerships program (CFDA 47.084), the project advances a hybrid computational approach utilizing multi-scale fluid analysis to enable faster-than-real-time simulation of viral particle dispersion and surface contamination in indoor environments. This will allow...
This National Science Foundation (NSF) Integrative Activities (CFDA 47.083) program grant for $282,862 awarded to Oklahoma State University (OSU) aims to investigate the health risks of e-cigarettes and cannabis aerosols, particularly those containing unregulated synthetic cooling agents. The project will utilize an advanced in vitro artificial lung system to quantify the exposure and toxicity levels of these vaping aerosols and assess variability in lung responses. The research objectives...
This National Science Foundation (NSF) Project Grant award under the Engineering program (CFDA 47.041) provides $200,000 to Oklahoma State University to develop advanced computational models and artificial intelligence tools to mitigate the spread of airborne viruses like SARS-CoV-2 in school classrooms. The key objectives are to: (1) Determine the distribution of virus-laden aerosols in classrooms using a model combining computational fluid dynamics and host cell dynamics to generate...
The U.S. Food and Drug Administration (FDA) awarded a $549,485 Cooperative Agreement under the FDA Research program (CFDA 93.103) to Oklahoma State University (OSU) for the project "ML-CFD-DEM Based Reduced Order Models (ROM) to Quantify Variability in Inhalers, Drugs, and Users for Evaluating Comparability of Generic OIDP Complex Products." The project aims to develop advanced computational fluid dynamics (CFD) and discrete element method (DEM) machine learning models, or AI-empowered...
Precision Theranostics Inc. was awarded a $256,000 Small Business Innovation Research Phase I Project Grant by the National Science Foundation Division of Industrial Innovation. The grant supports the development of a lung health diagnostic test for chronic obstructive pulmonary disease and prognosis-based early intervention from May 1, 2021 to April 30, 2022. The grant falls under the National Science Foundation's Engineering program (CFDA 47.041), which seeks to improve quality of life and...
This Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships program) provides $274,274 to X-Cor Therapeutics Inc., a minority-owned small disadvantaged business in Washington, DC, to develop a novel respiratory dialysis system for treating chronic obstructive pulmonary disease (COPD) patients. The project aims to optimize a prototype that can efficiently remove excess carbon dioxide from the blood of COPD patients, with the goal of...
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $427,811 Project Grant (CFDA 93.350) to the University of Delaware to develop an innovative "Total Inhalable Deposition in an Actuated Lung" (TIDAL) model. This multiscale dynamic preclinical tool aims to measure spatial deposition of inhaled aerosol therapeutics and vaccines as a function of patient-specific breathing, anatomy, and disease state. The project will validate the...
This federal Project Grant award of $229,454 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) supports the development of a fluorescence-based experimental apparatus capable of in situ measurements of the phase state, viscosity, and pH of size-resolved fine and ultrafine respiratory and drug aerosol particles. The goals of this 2-year project are to: 1) develop the fluorescence apparatus and establish the basis for...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Phase I Small Business Technology Transfer (STTR) award of $275,000 provides funding to Vivosphere LLC in Auburn, Alabama to develop a novel tissue-engineered platform for more effective cancer drug screening. The project aims to create a 3D hydrogel scaffold that provides a more physiologically relevant microenvironment for cell growth and drug response, enabling higher-throughput and more predictive...